TABLE 1.
Clinical features and outcomes of CG258 versus CG307 from Houston, TX
| Feature | Clonal Group |
P valuea | |
|---|---|---|---|
| CG258 (n = 27) | CG307 (n = 32) | ||
| Age (yr) (SD) | 60.7 (17.8) | 63.4 (18.3) | 0.72 |
| Male (%) | 14 (52) | 11 (34) | 0.20 |
| Ethnicity | 0.24% | ||
| Hispanic or Latino | 6 (22) | 4 (13) | |
| Not Hispanic or Latino | 18 (67) | 27 (84) | |
| Unknown | 2 (7) | 0 (0) | |
| Not reported | 1 (4) | 1 (3) | |
| Origin (%) | 0.75 | ||
| Home/transfer outside U.S. | 20 (74) | 24 (75) | |
| Long-term acute-care/hospital transfer | 1 (4) | 0 (0) | |
| Long-term-care hospice | 6 (22) | 8 (25) | |
| Charlson score (SD) | 2.6 (1.9) | 3.6 (2.5) | 0.13 |
| Pitt score (SD) | 2.6 (2.9) | 1.7 (1.9) | 0.30 |
| Renal dysfunction (yes) (%) | 7 (26) | 15 (47) | 0.11 |
| Culture source | 0.068% | ||
| Blood | 4 (15) | 0 (0) | |
| Respiratory | 7 (26) | 4 13) | |
| Urine | 10 (37) | 21 (66) | |
| Wound | 3 (11) | 4 (13) | |
| Other | 3 (11) | 3 (9) | |
| Infection (yes) (%) | 6 (22) | 9 (28) | 0.77 |
| Hospital duration (days) (SD) | 13.9 (14.8) | 10.8 (7.9) | 0.96 |
| 30-day mortality (%) | 8 (30) | 1 (3) | 0.008 |
a
Continuous outcomes tested with Wilcoxon rank sum test; Categorical outcomes tested with Fisher’s exact test.